A new investigation reveals how life insurance companies are increasingly denying claims for policyholders who die from opioid overdoses, citing exclusions or pre-existing conditions in fine print. Critics argue these practices disproportionately affect vulnerable populations already struggling with addiction, while insurers defend the decisions as standard underwriting policies. The report highlights discrepancies between marketing promises of financial protection and the reality faced by grieving families. Experts warn the trend could worsen as the opioid crisis continues to escalate.
